{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(2)"],"submitter":["Bastos-Oreiro M"],"journal":["HemaSphere"],"pagination":["e70077"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11792173"],"repository":["biostudies-literature"],"pubmed_title":["Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study."],"pmcid":["PMC11792173"],"pubmed_authors":["Iacoboni G","Zaberio I","Martin Garcia-Sancho A","Bastos-Oreiro M","Kwon M","Bailen R","Balaguer A","Hernani R","Gonzalez de Villambrosia S","Delgado J","Martinez N","Barba P","Garces VN","Caballero AC","Jimenez-Ubieto A"],"additional_accession":[]},"is_claimable":false,"name":"Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Feb","modification":"2025-04-04T01:24:14.33Z","creation":"2025-04-04T01:24:14.33Z"},"accession":"S-EPMC11792173","cross_references":{"pubmed":["39906687"],"doi":["10.1002/hem3.70077"]}}